SE9500023L - Sätt att detektera cancer - Google Patents

Sätt att detektera cancer

Info

Publication number: SE9500023L
Authority: SE; Sweden
Prior art keywords: amino; acid sequence; fusion proteins; polypeptides; homologues
Prior art date: 1994-05-17

Application number

SE9500023A

Other languages

Unknown language ( )

English (en)

Other versions

SE9500023D0 (sv

Inventor

Lars Rydlander

Peter Bjoerklund

Original Assignee

Beki Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-17

Filing date

1995-01-04

Publication date

1995-11-18

1994-05-17 Priority claimed from SE9401687A external-priority patent/SE9401687D0/sv

1995-01-04 Application filed by Beki Ab filed Critical Beki Ab

1995-01-04 Priority to SE9500023A priority Critical patent/SE9500023L/sv

1995-01-04 Publication of SE9500023D0 publication Critical patent/SE9500023D0/sv

1995-05-15 Priority to PCT/SE1995/000532 priority patent/WO1995031728A1/en

1995-05-15 Priority to AU25821/95A priority patent/AU2582195A/en

1995-05-15 Priority to JP7529563A priority patent/JPH10500408A/ja

1995-05-15 Priority to EP95920334A priority patent/EP0765479A1/en

1995-11-18 Publication of SE9500023L publication Critical patent/SE9500023L/sv

Links

206010028980 Neoplasm Diseases 0.000 title abstract 2
201000011510 cancer Diseases 0.000 title abstract 2
125000003275 alpha amino acid group Chemical group 0.000 abstract 3
102000037865 fusion proteins Human genes 0.000 abstract 3
108020001507 fusion proteins Proteins 0.000 abstract 3
229920001184 polypeptide Polymers 0.000 abstract 3
102000004196 processed proteins & peptides Human genes 0.000 abstract 3
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
108091032973 (ribonucleotides)n+m Proteins 0.000 abstract 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
238000009007 Diagnostic Kit Methods 0.000 abstract 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
210000001124 body fluid Anatomy 0.000 abstract 1
239000010839 body fluid Substances 0.000 abstract 1
230000000295 complement effect Effects 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4741—Keratin; Cytokeratin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Immunology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

SE9500023A 1994-05-17 1995-01-04 Sätt att detektera cancer SE9500023L (sv)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
SE9500023A SE9500023L (sv)	1994-05-17	1995-01-04	Sätt att detektera cancer
PCT/SE1995/000532 WO1995031728A1 (en)	1994-05-17	1995-05-15	Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies
AU25821/95A AU2582195A (en)	1994-05-17	1995-05-15	Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies
JP7529563A JPH10500408A (ja)	1994-05-17	1995-05-15	サイトケラチン１８のフラグメントおよび対応する抗体を伴う癌の検出法
EP95920334A EP0765479A1 (en)	1994-05-17	1995-05-15	Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9401687A SE9401687D0 (sv)	1994-05-17	1994-05-17	Method of detecting cancer
SE9500023A SE9500023L (sv)	1994-05-17	1995-01-04	Sätt att detektera cancer

Publications (2)

Publication Number	Publication Date
SE9500023D0 SE9500023D0 (sv)	1995-01-04
SE9500023L true SE9500023L (sv)	1995-11-18

Family

ID=26662055

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9500023A SE9500023L (sv)	1994-05-17	1995-01-04	Sätt att detektera cancer

Country Status (5)

Country	Link
EP (1)	EP0765479A1 (sv)
JP (1)	JPH10500408A (sv)
AU (1)	AU2582195A (sv)
SE (1)	SE9500023L (sv)
WO (1)	WO1995031728A1 (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5670325A (en) *	1996-08-14	1997-09-23	Exact Laboratories, Inc.	Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
ES2150064T3 (es) *	1996-01-18	2000-11-16	Aventis Pharma Gmbh	Un sustrato recombinante artificial (ragg-1) y agrecano nativo para estudiar la actividad proteolitica de la "agrecanasa" en sistemas de cultivo celular.
US5741650A (en) *	1996-01-30	1998-04-21	Exact Laboratories, Inc.	Methods for detecting colon cancer from stool samples
US5928870A (en) *	1997-06-16	1999-07-27	Exact Laboratories, Inc.	Methods for the detection of loss of heterozygosity
US5952178A (en) *	1996-08-14	1999-09-14	Exact Laboratories	Methods for disease diagnosis from stool samples
US6203993B1 (en)	1996-08-14	2001-03-20	Exact Science Corp.	Methods for the detection of nucleic acids
US6300077B1 (en)	1996-08-14	2001-10-09	Exact Sciences Corporation	Methods for the detection of nucleic acids
US6100029A (en) *	1996-08-14	2000-08-08	Exact Laboratories, Inc.	Methods for the detection of chromosomal aberrations
US6146828A (en) *	1996-08-14	2000-11-14	Exact Laboratories, Inc.	Methods for detecting differences in RNA expression levels and uses therefor
US6020137A (en) *	1996-08-14	2000-02-01	Exact Laboratories, Inc.	Methods for the detection of loss of heterozygosity
WO1999014372A1 (en) *	1997-09-15	1999-03-25	Abbott Laboratories	Reagents and methods useful for detecting diseases of the urinary tract
US7393529B2 (en)	1998-04-09	2008-07-01	Idexx Laboratories, Inc.	Methods and compositions for inhibiting binding of IgE to a high affinity receptor
US6734287B1 (en) *	1998-04-09	2004-05-11	Idexx Laboratories, Inc.	Specific binding proteins for treating canine allergy
US6280947B1 (en)	1999-08-11	2001-08-28	Exact Sciences Corporation	Methods for detecting nucleotide insertion or deletion using primer extension
US6964846B1 (en)	1999-04-09	2005-11-15	Exact Sciences Corporation	Methods for detecting nucleic acids indicative of cancer
CA2380979A1 (en) *	1999-08-13	2001-02-22	Brigham And Women's Hospital, Inc.	Inhibitors of the lectin complement pathway (lcp) and their use
US6849403B1 (en)	1999-09-08	2005-02-01	Exact Sciences Corporation	Apparatus and method for drug screening
US6919174B1 (en)	1999-12-07	2005-07-19	Exact Sciences Corporation	Methods for disease detection
AU4714201A (en)	1999-12-07	2001-06-18	Exact Sciences Corporation	Supracolonic aerodigestive neoplasm detection
WO2002055555A2 (en) *	2000-12-21	2002-07-18	Genzyme Corp	Antigenic ck-18 compounds for therapy and diagnosis and methods for using same
WO2003086456A2 (en) *	2002-04-05	2003-10-23	Arius Research, Inc.	Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer
WO2005074968A2 (en) *	2004-02-10	2005-08-18	Universiteit Maastricht	Medical use of basic peptides
WO2006047787A2 (en)	2004-10-27	2006-05-04	Exact Sciences Corporation	Method for monitoring disease progression or recurrence
US9777314B2 (en)	2005-04-21	2017-10-03	Esoterix Genetic Laboratories, Llc	Analysis of heterogeneous nucleic acid samples
CA2634797A1 (en) *	2005-12-22	2007-07-05	Abbott Laboratories	Methods and marker combinations for screening for predisposition to lung cancer
US8524453B2 (en)	2006-02-10	2013-09-03	The Brigham And Woman's Hospital, Inc.	Lectin complement pathway assays and related compositions and methods
US7883904B2 (en)	2006-05-19	2011-02-08	The Cleveland Clinic Foundation	Detection and monitoring of liver damage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE125626T1 (de) *	1984-01-06	1995-08-15	Univ California	Cytokeratin-tumormarkierer und test zu deren nachweis.
DE3815932A1 (de) *	1988-01-26	1989-08-03	Progen Biotechnik Gmbh	Verfahren zur identifizierung des ursprungs einer zellgewebsprobe
DE3923951A1 (de) *	1989-07-19	1991-01-31	Boehringer Mannheim Gmbh	Verfahren zum nachweis von leberzirrhose

1995
- 1995-01-04 SE SE9500023A patent/SE9500023L/sv not_active Application Discontinuation
- 1995-05-15 AU AU25821/95A patent/AU2582195A/en not_active Abandoned
- 1995-05-15 WO PCT/SE1995/000532 patent/WO1995031728A1/en not_active Ceased
- 1995-05-15 JP JP7529563A patent/JPH10500408A/ja active Pending
- 1995-05-15 EP EP95920334A patent/EP0765479A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
WO1995031728A1 (en)	1995-11-23
EP0765479A1 (en)	1997-04-02
SE9500023D0 (sv)	1995-01-04
JPH10500408A (ja)	1998-01-13
AU2582195A (en)	1995-12-05

Publication	Publication Date	Title
SE9500023L (sv)	1995-11-18	Sätt att detektera cancer
CO4870792A1 (es)	1999-12-27	Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata
WO1998050554A3 (en)	1999-04-01	Enterococcus faecalis polynucleotides and polypeptides
TR200000113T2 (tr)	2000-05-22	Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri.
MX9801687A (es)	1998-11-29	Compuestos y metodos para el diagnostico de tuberculosis.
CA2131826A1 (en)	1993-09-16	MN Gene and Protein
CA2286304A1 (en)	1998-10-15	Pca3, pca3 genes, and methods of use
DE60026332D1 (de)	2006-04-27	Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
WO1997033909A3 (en)	1997-12-24	Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
DE69638162D1 (de)	2010-05-27	Bindegewebs wachstumsfaktor (ctgf)
WO1998016645A3 (en)	1998-08-06	Compounds and methods for diagnosis of tuberculosis
NL300118I1 (nl)	2003-06-02	Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
CA2272845A1 (en)	1998-06-04	Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
WO1994023030A3 (en)	1994-11-10	Methods and materials relating to the functional domains of dna binding proteins
CA2192940A1 (en)	1995-12-28	Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
DE60043944D1 (de)	2010-04-15	Zytokin zcyt018
WO1999047639A3 (en)	2001-08-23	Staphylococcus aureus genes and polypeptides
ATE225942T1 (de)	2002-10-15	Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv)
ATE433463T1 (de)	2009-06-15	Monospezifische antikörper gegen fibrinogen und fibrinopeptide b
AU7564491A (en)	1991-10-21	New proteins, peptides and corresponding dna or rna sequences and probes useful for diagnosing tuberculosis
Heck et al.	1986	Isolation, characterization, and amino-terminal amino acid sequence analysis of human neutrophil cathepsin G from normal donors
DK0535150T3 (da)	1995-05-15	Humant makrofag-inflammatorisk protein-2-beta
WO1998054212A3 (de)	1999-03-11	Das protein des humanen ryanodinrezeptors vom typ 3 sowie dafür kodierende dna-moleküle
BR0010479A (pt)	2003-04-29	Gene tipo prp
WO1999018210A3 (en)	1999-08-05	Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer

Legal Events

Date	Code	Title	Description
1998-11-02	NAV	Patent application has lapsed	Ref document number: 9500023-8 Format of ref document f/p: F

Date

Code

Title

Description

1998-11-02

NAV

Patent application has lapsed

Ref document number: 9500023-8

Format of ref document f/p: F